Five-mRNA Signature for the Prognosis of Breast Cancer Based on the ceRNA Network

Abstract

Background. The purpose of this study was to investigate the regulatory mechanisms of ceRNAs in breast cancer (BC) and construct a new five-mRNA prognostic signature. Methods. The ceRNA network was constructed by different RNAs screened by the edgeR package. The BC prognostic signature was built based on the Cox regression analysis. The log-rank method was used to analyse the survival rate of BC patients with different risk scores. The expression of the 5 genes was verified by the GSE81540 dataset and CPTAC database. Results. A total of 41 BC-adjacent tissues and 473 BC tissues were included in this study. A total of 2,966 differentially expressed lncRNAs, 5,370 differentially expressed mRNAs, and 359 differentially expressed miRNAs were screened. The ceRNA network was constructed using 13 lncRNAs, 267 mRNAs, and 35 miRNAs. Kaplan-Meier (K-M) methods showed that two lncRNAs (AC037487.1 and MIR22HG) are related to prognosis. Five mRNAs (VPS28, COL17A1, HSF1, PUF60, and SMOC1) in the ceRNA network were used to establish a prognostic signature. Survival analysis showed that the prognosis of patients in the low-risk group was significantly better than that in the high-risk group (p=0.0022). ROC analysis showed that this signature has a good diagnostic ability (AUC=0.77). Compared with clinical features, this signature was also an independent prognostic factor (HR: 1.206, 95% CI 1.108−1.311; p<0.001). External verification results showed that the expression of the 5 mRNAs differed between the normal and tumour groups at the chip and protein levels (p<0.001). Conclusions. These ceRNAs may play a key role in the development of BC, and the new 5-mRNA prognostic signature can improve the prediction of survival for BC patients.

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Estrogen Receptor (ER) or Progesterone Receptor (PR) Positive and Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

“…[19,20] Besides, ndings from our analysis added more evidence on the protective effect of COL17A1, SLC7A2 and CCL19 expression in breast cancer. [21][22][23] On the other hand, the association between ATP6AP1 ,AGA and FLT3 expression and prognosis in breast cancer were rstly reported.…”

Identification of Six Genes as Diagnostic Markers for Colorectal Cancer Detection by Integrating Multiple Expression Profiles

“…Molecular marker assays present several practical advantages when comparing with the current widely used methods [15] and a series of prognostic signatures are identified for cancers [16][17][18][19]. In particular, noninvasive tests such as fecal-based biomarkers provide a chance for early CRC diagnosis.…”

Bioinformatics Analysis Reveals an Association between Autophagy, Prognosis, Tumor Microenvironment, and Immunotherapy in Osteosarcoma

“…e high level of cellular heterogeneity and the complexity of molecular and genetic mechanisms associated with osteosarcoma make the clinical treatment of metastatic osteosarcoma extremely di cult [4]. For the past few years, the increasing feasibility of molecular pro ling together with the creation of both robust model systems [5][6][7] and large, well-annotated tissue banks has led to an increased understanding of osteosarcoma biology [8].…”